Grants and Contracts Details
| Status | Finished |
|---|---|
| Effective start/end date | 12/6/21 → 5/31/24 |
Funding
- Syneos Health LLC: $71,496.00
BHV3000-312: Phase 3, Multicenter, Randomized, Double-blind, Group Sequential, Placebo-controlled Study to Assess Efficacy and Safety of Rimegepant for the Treatment of Migraine (With or Without Aura) in Children and Adolescents 6 to <18 Years of Age
- Qaiser, Sharoon (PI)